CVS CVS HEALTH Corp stock chart & analysis
Conviction 52HealthcareScan · Fri, Nov 6, 2026CVS HEALTH Corp (CVS) closed at $83.85 (+3.10%) on Nov 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 40, RS Rating 46, -24.3% from its 52-week high, +5.7% year to date. Sector: Healthcare · Retail-Drug Stores and Proprietary Stores.
Financials as of Wed, Sep 30, 2026 · quarterly.
CVS technical analysis
Trend
CVS's moving averages are mixed — no clean uptrend or downtrend. It closed 7.2% below the 50-day ($90.38) and 5.7% below the 200-day ($88.89). ADX(14) at 23 points to a moderate trend. It meets 3 of 8 trend-template criteria.
Momentum
RSI(14) is 40, in the bearish half of its range. MACD crossed below its signal line 5 sessions ago. Its RS Rating of 46 puts its weighted 12-month performance ahead of about 46% of the US market.
Volume and volatility
Volume on the latest session ran 1.3× its 20-day average. It trades about $937.0M a day on average. ATR(14) is $3.23, 3.9% of price — its typical daily range. Chaikin Money Flow (0.06) shows accumulation.
Key levels
The chart pattern's support is $80.78 and its resistance $93.61. The 52-week range is $69.51 to $110.68; price is 24.3% below the high and 20.6% above the low. The VWAP anchored at the 52-week high is $92.10, above price.
Performance
CVS returned -7.1% (1 week), -4.5% (1 month), -12.4% (3 months), -7.4% (6 months), +6.7% (1 year), +5.7% (year to date).
About CVS HEALTH Corp
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
Retail-Drug Stores and Proprietary Stores · Listed 1952 · 300,000 employees
Recent news
- CVS to Restart Share Buybacks in Q4, Reflecting Confidence in FiGuruFocus · Wed, Nov 4, 2026
- CVS Health To Split Into Two Companies As Pressure Mounts On Vertical IntegrationForbes · Wed, Nov 4, 2026
- CVS Health Q3 2026 Earnings Call TranscriptBenzinga · Wed, Nov 4, 2026
- An Honest Take on Motherhood and Mental HealthYahoo Finance · Wed, Nov 4, 2026
- CVS to split into two companies, in major breakup of its $117 billion healthcare empireCnn · Wed, Nov 4, 2026
- Is CVS Health a Buy After Split Plan, Q3 Beat and Higher Guidance?NAI500 · Wed, Nov 4, 2026
- CVS Health To Spinoff Its Retail Pharmacy ChainTradingView · Wed, Nov 4, 2026
- CVS Health Swings To Q3 Profit, Lifts FY26 Outlook; To Split Into Two; Shares DropRTTNews · Wed, Nov 4, 2026
- CVS Health shares plans to create two distinct leaders in healthcareMass Market Retailers · Wed, Nov 4, 2026
- CVS Health is splitting into two companies, separating its pharmacies from insuranceQuartz · Wed, Nov 4, 2026
Congress activity
Disclosed STOCK Act trades in CVS · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-08-26 | Sell | $1K–$15K | 2024-08-26 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
 John Boozman senate · R · AR · traded 2026-01-29 | Buy | $1K–$15K | 2026-01-29 | 2026-02-15 | |
 Dwight Evans house · PA · traded 2025-11-21 | Sell | $1K–$15K | 2025-11-21 | 2025-12-05 | |
 Lisa McClain house · MI · traded 2025-10-31 | Sell | $1K–$15K | 2025-10-31 | 2025-11-01 | |
Lisa McClain house · MI · traded 2025-10-30 | Buy | $1K–$15K | 2025-10-30 | 2025-11-01 | |
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
 Adam Smith house · D · WA · traded 2025-08-08 | Sell | $1K–$15K | 2025-08-08 | 2025-08-08 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 |
Insider activity
SEC Form 4 transactions in CVS · open-market 1 buy · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Shah Prem S EVP and Group President · Common Stock · 2026-11-06 | Buy | 23.86K | $2.0M | 2026-11-06 | 2026-11-06 |
Clark James David SVP, Cont & Chief Acct Officer · Common Stock (Restricted) · 2026-06-26 | Tax | 454 | $41K | 2026-06-26 | 2026-06-29 |
Newman Brian EVP, Chief Financial Officer · Common Stock · 2026-05-31 | Tax | 2.48K | $225K | 2026-05-31 | 2026-06-01 |
Compton-Phillips Amy EVP, Chief Medical Officer · Common Stock · 2026-05-31 | Tax | 7.62K | $693K | 2026-05-31 | 2026-06-01 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-21 | Disposition | 1.56K | $146K | 2026-05-21 | 2026-05-22 |
AGUIRRE FERNANDO Director · Common Stock · 2026-05-20 | Disposition | 30.44K | $2.9M | 2026-05-20 | 2026-05-22 |
ROBBINS LARRY Director · Cash-Settled Swaps · 2026-05-21 | Sell | 378K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-21 | Sell | 370.46K | $35M | 2026-05-21 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 797.63K | $75M | 2026-05-20 | 2026-05-21 |
ROBBINS LARRY Director · Common Stock · 2026-05-20 | Sell | 800 | $77K | 2026-05-20 | 2026-05-21 |
SEC filings
EDGAR filings in CVS · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.